DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Seymour L. et al.
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.
Lancet Oncol 2017;
18: e143-e152 . DOI: 10.1016/S1470-2045(17)30074-8
We do not assume any responsibility for the contents of the web pages of other providers.